Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis

References

• Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999; 20: 114–118
   PubMedGoogle Scholar
• Naccasha N, Gervasi M T, Chaiworapongsa T, Berman S, Yoon B H, Maymon E, Romero R. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol 2001; 185: 1118–1123
   PubMed Web of Science ®Google Scholar
• Kort B A, Cefalo R C, Baker V V. Fatal influenza A pneumonia in pregnancy. Am J Perinatol 1986; 3: 179–182
   PubMed Web of Science ®Google Scholar
• Rodrigues J, Niederman M S. Pneumonia complicating pregnancy. Clin Chest Med 1992; 13: 679–691
   PubMed Web of Science ®Google Scholar
• Kochar D K, Thanvi I, Joshi A, Shubhakaran, Agarwal N, Jain N. Mortality trends in falciparum malaria—effect of gender difference and pregnancy. J Assoc Physicians India 1999; 47: 774–778
   PubMedGoogle Scholar
• Laibl V R, Sheffield J S. Influenza and pneumonia in pregnancy. Clin Perinatol 2005; 32: 727–738
   PubMed Web of Science ®Google Scholar
• Cox S, Posner S F, McPheeters M, Jamieson D J, Kourtis A P, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol 2006; 107: 1315–1322
   PubMed Web of Science ®Google Scholar
• Muller-Berghaus G, Obst R. Induction of the generalized Shwartzman reaction in pregnant and nonpregnant rats by colchicine. Am J Pathol 1972; 69: 131–138
   PubMed Web of Science ®Google Scholar
• Muller-Berghaus G, Schmidt-Ehry B. The role of pregnancy in the induction of the generalized Shwartzman reaction. Am J Obstet Gynecol 1972; 114: 847–849
   PubMed Web of Science ®Google Scholar
• Mori W. The Shwartzman reaction: A review including clinical manifestations and proposal for a univisceral or single organ third type. Histopathology 1981; 5: 113–126
   PubMed Web of Science ®Google Scholar
• Cunningham F G, Leveno K J, Hankins G D, Whalley P J. Respiratory insufficiency associated with pyelonephritis during pregnancy. Obstet Gynecol 1984; 63: 121–125
   PubMed Web of Science ®Google Scholar
• Elkington K W, Greb L C. Adult respiratory distress syndrome as a complication of acute pyelonephritis during pregnancy: Case report and discussion. Obstet Gynecol 1986; 67: 18S–20S
   PubMed Web of Science ®Google Scholar
• Cunningham F G, Lucas M J, Hankins G D. Pulmonary injury complicating antepartum pyelonephritis. Am J Obstet Gynecol 1987; 156: 797–807
   PubMed Web of Science ®Google Scholar
• Pruett K, Faro S. Pyelonephritis associated with respiratory distress. Obstet Gynecol 1987; 69: 444–446
   PubMed Web of Science ®Google Scholar
• Gurman G, Schlaeffer F, Kopernic G. Adult respiratory distress syndrome as a complication of acute pyelonephritis during pregnancy. Eur J Obstet Gynecol Reprod Biol 1990; 36: 75–80
   PubMed Web of Science ®Google Scholar
• Amstey M S. Frequency of adult respiratory distress syndrome in pregnant women who have pyelonephritis. Clin Infect Dis 1992; 14: 1260–1261
   PubMed Web of Science ®Google Scholar
• Mabie W C, Barton J R, Sibai B M. Adult respiratory distress syndrome in pregnancy. Am J Obstet Gynecol 1992; 167: 950–957
   PubMed Web of Science ®Google Scholar
• Catanzarite V A, Willms D. Adult respiratory distress syndrome in pregnancy: Report of three cases and review of the literature. Obstet Gynecol Surv 1997; 52: 381–392
   PubMedGoogle Scholar
• Catanzarite V, Willms D, Wong D, Landers C, Cousins L, Schrimmer D. Acute respiratory distress syndrome in pregnancy and the puerperium: Causes, courses, and outcomes. Obstet Gynecol 2001; 97: 760–764
   PubMed Web of Science ®Google Scholar
• Cole D E, Taylor T L, McCullough D M, Shoff C T, Derdak S. Acute respiratory distress syndrome in pregnancy. Crit Care Med 2005; 33: S269–S278
   PubMed Web of Science ®Google Scholar
• Hill J B, Sheffield J S, McIntire D D, Wendel G D, Jr. Acute pyelonephritis in pregnancy. Obstet Gynecol 2005; 105: 18–23
   PubMed Web of Science ®Google Scholar
• Smith C A, Davis T, Anderson D, Solam L, Beckmann M P, Jerzy R, Dower S K, Cosman D, Goodwin R G. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248: 1019–1023
   PubMed Web of Science ®Google Scholar
• Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992; 68: 421–427
   PubMed Web of Science ®Google Scholar
• Smith C A, Gruss H J, Davis T, Anderson D, Farrah T, Baker E, Sutherland G R, Brannan C I, Copeland N G, Jenkins N A, et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993; 73: 1349–1360
   PubMed Web of Science ®Google Scholar
• Del Prete G, De Carli M, Almerigogna F, Daniel C K, D'Elios M M, Zancuoghi G, Vinante F, Pizzolo G, Romagnani S. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995; 9: 81–86
   PubMed Web of Science ®Google Scholar
• Romagnani S, Del Prete G, Maggi E, Chilosi M, Caligaris-Cappio F, Pizzolo G. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol 1995; 57: 726–730
   PubMed Web of Science ®Google Scholar
• Hansen H P, Kisseleva T, Kobarg J, Horn-Lohrens O, Havsteen B, Lemke H. A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines. Int J Cancer 1995; 63: 750–756
   PubMed Web of Science ®Google Scholar
• Hansen H P, Dietrich S, Kisseleva T, Mokros T, Mentlein R, Lange H H, Murphy G, Lemke H. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme. J Immunol 2000; 165: 6703–6709
   PubMed Web of Science ®Google Scholar
• Kusanovic J P, Romero R, Hassan S, Gotsch F, Edwin S, Erez O, Mittal P, Mazaki-Tovi S, Soto E, Than N G, et al. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. J Matern Fetal Neonatal Med 2007
   Web of Science ®Google Scholar
• Pizzolo G, Vinante F, Nadali G, Krampera M, Morosato L, Chilosi M, Raiteri R, Sinicco A. High serum level of soluble CD30 in acute primary HIV-1 infection. Clin Exp Immunol 1997; 108: 251–253
   PubMed Web of Science ®Google Scholar
• Fattovich G, Vinante F, Giustina G, Morosato L, Alberti A, Ruol A, Pizzolo G. Serum levels of soluble CD30 in chronic hepatitis B virus infection. Clin Exp Immunol 1996; 103: 105–110
   PubMed Web of Science ®Google Scholar
• Monsalve F, Romero A, Estevez J, Costa L, Callejas D. [Serum levels of soluble CD30 molecule in hepatitis B virus infection]. Rev Med Chil 2001; 129: 1248–1252
   PubMed Web of Science ®Google Scholar
• Wang G, Hansen H, Tatsis E, Csernok E, Lemke H, Gross W L. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Am J Med 1997; 102: 517–523
   PubMed Web of Science ®Google Scholar
• Grusell M, Widhe M, Ekerfelt C. Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis. J Neuroimmunol 2002; 131: 173–178
   PubMed Web of Science ®Google Scholar
• Lienhardt C, Azzurri A, Amedei A, Fielding K, Sillah J, Sow O Y, Bah B, Benagiano M, Diallo A, Manetti R, et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 2002; 32: 1605–1613
   PubMed Web of Science ®Google Scholar
• Alexander G R, Himes J H, Kaufman R B, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87: 163–168
   PubMed Web of Science ®Google Scholar
• Levy M M, Fink M P, Marshall J C, Abraham E, Angus D, Cook D, Cohen J, Opal S M, Vincent J L, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250–1256
   PubMed Web of Science ®Google Scholar
• Soto E, Richani K, Romero R, Espinoza J, Chaiworapongsa T, Nien J K, Edwin S, Kim Y M, Hong J S, Goncalves L, et al. Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med 2005; 17: 247–252
   PubMed Web of Science ®Google Scholar
• Gotsch F, Romero R, Espinoza J, Kusanovic J P, Mazaki-Tovi S, Erez O, Than N G, Edwin S, Mazor M, Yoon B H, Hassan S. Maternal serum contraceptions of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med 2007
   Web of Science ®Google Scholar
• Efrati P, Presentey B, Margalith M, Rozenszajn L. Leukocytes of normal pregnant women. Obstet Gynecol 1964; 23: 429–432
   PubMed Web of Science ®Google Scholar
• Stirling Y, Woolf L, North W R, Seghatchian M J, Meade T W. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176–182
   PubMed Web of Science ®Google Scholar
• Comeglio P, Fedi S, Liotta A A, Cellai A P, Chiarantini E, Prisco D, Mecacci F, Parretti E, Mello G, Abbate R. Blood clotting activation during normal pregnancy. Thromb Res 1996; 84: 199–202
   PubMed Web of Science ®Google Scholar
• Hopkinson N D, Powell R J. Classical complement activation induced by pregnancy: Implications for management of connective tissue diseases. J Clin Pathol 1992; 45: 66–67
   PubMed Web of Science ®Google Scholar
• Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien J K, Edwin S, Kim Y M, Hong J S, Mazor M. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 2005; 17: 239–245
   PubMed Web of Science ®Google Scholar
• Sacks G P, Studena K, Sargent K, Redman C W. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179: 80–86
   PubMed Web of Science ®Google Scholar
• Luppi P, Haluszczak C, Trucco M, DeLoia J A. Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol 2002; 47: 72–81
   PubMed Web of Science ®Google Scholar
• von Dadelszen P, Watson R W, Noorwali F, Marshall J C, Parodo J, Farine D, Lye S J, Ritchie J W, Rotstein O D. Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol 1999; 181: 408–414
   PubMed Web of Science ®Google Scholar
• Luppi P, Haluszczak C, Betters D, Richard C A, Trucco M, DeLoia J A. Monocytes are progressively activated in the circulation of pregnant women. J Leukoc Biol 2002; 72: 874–884
   PubMed Web of Science ®Google Scholar
• Sacks G P, Redman C W, Sargent I L. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: An intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol 2003; 131: 490–497
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Gerosa F. Immunoregulation by interleukin-12. J Leukoc Biol 1996; 59: 505–511
   PubMed Web of Science ®Google Scholar
• Gilstrap L C, III, Cunningham F G, Whalley P J. Acute pyelonephritis in pregnancy: An anterospective study. Obstet Gynecol 1981; 57: 409–413
   PubMed Web of Science ®Google Scholar
• Bacak S J, Callaghan W M, Dietz P M, Crouse C. Pregnancy-associated hospitalizations in the United States, 1999–2000. Am J Obstet Gynecol 2005; 192: 592–597
   PubMed Web of Science ®Google Scholar
• Mittal P, Wing D A. Urinary tract infections in pregnancy. Clin Perinatol 2005; 32: 749–764
   PubMed Web of Science ®Google Scholar
• Bubeck R W. Acute pyelonephritis during pregnancy with anuria, septicemia and thrombocytopenia. Del Med J 1968; 40: 143–147
   PubMedGoogle Scholar
• Mabie W C, Barton J R, Sibai B. Septic shock in pregnancy. Obstet Gynecol 1997; 90: 553–561
   PubMed Web of Science ®Google Scholar
• Sheffield J S. Sepsis and septic shock in pregnancy. Crit Care Clin 2004; 20: 651–660
   PubMed Web of Science ®Google Scholar
• Zeeman G G, Wendel G D, Jr, Cunningham F G. A blueprint for obstetric critical care. Am J Obstet Gynecol 2003; 188: 532–536
   PubMed Web of Science ®Google Scholar
• Bone R C, Grodzin C J, Balk R A. Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997; 112: 235–243
   PubMed Web of Science ®Google Scholar
• Bone R C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24: 1125–1128
   PubMed Web of Science ®Google Scholar
• Oberholzer A, Oberholzer C, Moldawer L L. Sepsis syndromes: Understanding the role of innate and acquired immunity. Shock 2001; 16: 83–96
   PubMed Web of Science ®Google Scholar
• Osuchowski M F, Welch K, Siddiqui J, Remick D G. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006; 177: 1967–1974
   PubMed Web of Science ®Google Scholar
• Bone R C. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996; 125: 680–687
   PubMed Web of Science ®Google Scholar
• Takahashi H, Tsuda Y, Kobayashi M, Herndon D N, Suzuki F. CCL2 as a trigger of manifestations of compensatory anti-inflammatory response syndrome in mice with severe systemic inflammatory response syndrome. J Leukoc Biol 2006; 79: 789–796
   PubMed Web of Science ®Google Scholar
• Hotchkiss R S, Karl I E. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138–150
   PubMed Web of Science ®Google Scholar
• Meakins J L, Pietsch J B, Bubenick O, Kelly R, Rode H, Gordon J, MacLean L D. Delayed hypersensitivity: Indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg 1977; 186: 241–250
   PubMed Web of Science ®Google Scholar
• Lederer J A, Rodrick M L, Mannick J A. The effects of injury on the adaptive immune response. Shock 1999; 11: 153–159
   PubMed Web of Science ®Google Scholar
• Rogy M A, Coyle S M, Oldenburg H S, Rock C S, Barie P S, Van Zee K J, Smith C G, Moldawer L L, Lowry S F. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg 1994; 178: 132–138
   PubMed Web of Science ®Google Scholar
• Neidhardt R, Keel M, Steckholzer U, Safret A, Ungethuem U, Trentz O, Ertel W. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1997; 42: 863–870
   PubMedGoogle Scholar
• Gogos C A, Drosou E, Bassaris H P, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options. J Infect Dis 2000; 181: 176–180
   PubMed Web of Science ®Google Scholar
• Ashare A, Powers L S, Butler N S, Doerschug K C, Monick M M, Hunninghake G W. Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am J Physiol Lung Cell Mol Physiol 2005; 288: L633–L640
   PubMed Web of Science ®Google Scholar
• Ferguson N R, Galley H F, Webster N R. T helper cell subset ratios in patients with severe sepsis. Intensive Care Med 1999; 25: 106–109
   PubMed Web of Science ®Google Scholar
• Opal S M, DePalo V A. Anti-inflammatory cytokines. Chest 2000; 117: 1162–1172
   PubMed Web of Science ®Google Scholar
• Romagnani S. Understanding the role of Th1/Th2 cells in infection. Trends Microbiol 1996; 4: 470–473
   PubMed Web of Science ®Google Scholar
• O'Sullivan S T, Lederer J A, Horgan A F, Chin D H, Mannick J A, Rodrick M L. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222: 482–490
   PubMed Web of Science ®Google Scholar
• Murphey E D, Lin C Y, McGuire R W, Toliver-Kinsky T, Herndon D N, Sherwood E R. Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression. Shock 2004; 21: 415–425
   PubMed Web of Science ®Google Scholar
• Froese P, Lemke H, Gerdes J, Havsteen B, Schwarting R, Hansen H, Stein H. Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines. J Immunol 1987; 139: 2081–2087
   PubMed Web of Science ®Google Scholar
• Nawrocki J F, Kirsten E S, Fisher R I. Biochemical and structural properties of a Hodgkin's disease-related membrane protein. J Immunol 1988; 141: 672–680
   PubMed Web of Science ®Google Scholar
• Falini B, Pileri S, Pizzolo G, Durkop H, Flenghi L, Stirpe F, Martelli M F, Stein H. CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85: 1–14
   PubMed Web of Science ®Google Scholar
• Josimovic-Alasevic O, Durkop H, Schwarting R, Backe E, Stein H, Diamantstein T. Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay. Eur J Immunol 1989; 19: 157–162
   PubMed Web of Science ®Google Scholar
• Stein H, Mason D Y, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed–Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858
   PubMed Web of Science ®Google Scholar
• Schwarting R, Gerdes J, Durkop H, Falini B, Pileri S, Stein H. BER-H2: A new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989; 74: 1678–1689
   PubMed Web of Science ®Google Scholar
• Ito K, Watanabe T, Horie R, Shiota M, Kawamura S, Mori S. High expression of the CD30 molecule in human decidual cells. Am J Pathol 1994; 145: 276–280
   PubMed Web of Science ®Google Scholar
• Gruss H J, Boiani N, Williams D E, Armitage R J, Smith C A, Goodwin R G. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994; 83: 2045–2056
   PubMed Web of Science ®Google Scholar
• Lee S Y, Park C G, Choi Y. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med 1996; 183: 669–674
   PubMed Web of Science ®Google Scholar
• Horie R, Watanabe T. CD30: Expression and function in health and disease. Semin Immunol 1998; 10: 457–470
   PubMed Web of Science ®Google Scholar
• Chilosi M, Facchetti F, Notarangelo L D, Romagnani S, Del Prete G, Almerigogna F, De Carli M, Pizzolo G. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2-mediated condition. Eur J Immunol 1996; 26: 329–334
   PubMed Web of Science ®Google Scholar
• Pizzolo G, Vinante F, Chilosi M, Dallenbach F, Josimovic-Alasevic O, Diamantstein T, Stein H. Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: Relationship with disease activity and clinical stage. Br J Haematol 1990; 75: 282–284
   PubMed Web of Science ®Google Scholar
• Nadali G, Vinante F, Ambrosetti A, Todeschini G, Veneri D, Zanotti R, Meneghini V, Ricetti M M, Benedetti F, Vassanelli A, et al. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J Clin Oncol 1994; 12: 793–797
   PubMed Web of Science ®Google Scholar
• Pizzolo G, Vinante F, Morosato L, Nadali G, Chilosi M, Gandini G, Sinicco A, Raiteri R, Semenzato G, Stein H, et al. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 1994; 8: 741–745
   PubMed Web of Science ®Google Scholar
• Nadali G, Tavecchia L, Zanolin E, Bonfante V, Viviani S, Camerini E, Musto P, Di Renzo N, Carotenuto M, Chilosi M, et al. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome. Blood 1998; 91: 3011–3016
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Pileri S, Bendandi M, Buzzi M, Sabattini E, Ascani S, Gherlinzoni F, Magagnoli M, Albertini P, Tura S. Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients. J Clin Oncol 1998; 16: 1532–1537
   PubMed Web of Science ®Google Scholar
• Vinante F, Morosato L, Siviero F, Nadali G, Rigo A, Veneri D, de Sabata D, Vincenzi C, Chilosi M, Semenzato G, et al. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis. Haematologica 1994; 79: 413–419
   PubMed Web of Science ®Google Scholar
• Hoshimoto K, Ohta N, Ohkura T, Inaba N. Changes in plasma soluble CD26 and CD30 during pregnancy: Markers of Th1/Th2 balance?. Gynecol Obstet Invest 2000; 50: 260–263
   PubMed Web of Science ®Google Scholar
• Ostensen M, Forger F, Nelson J L, Schuhmacher A, Hebisch G, Villiger P M. Pregnancy in patients with rheumatic disease: Anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 2005; 64: 839–844
   PubMed Web of Science ®Google Scholar
• Ekstrom E S, Bengtsson A, Svensson A, Nilsson C, Ostlund E, Sandstedt B, Bremme K, Lilja G, Scheynius A. Presence of CD30(+) and CD30L(+) cells in human placenta and soluble CD30 levels in cord blood are independent of maternal atopy. Placenta 2001; 22: 372–379
   PubMed Web of Science ®Google Scholar
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864–874
   PubMed Web of Science ®Google Scholar
• Martin S R, Foley M R. Intensive care in obstetrics: An evidence-based review. Am J Obstet Gynecol 2006; 195: 673–689
   PubMed Web of Science ®Google Scholar
• Wegmann T G, Lin H, Guilbert L, Mosmann T R. Bidirectional cytokine interactions in the maternal–fetal relationship: Is successful pregnancy a TH2 phenomenon?. Immunol Today 1993; 14: 353–356
   PubMedGoogle Scholar
• Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. Reproductive immunology 2003: Reassessing the Th1/Th2 paradigm?. Immunol Lett 2004; 92: 207–214
   PubMed Web of Science ®Google Scholar
• Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. TH1/TH2 paradigm in pregnancy: Paradigm lost? Cytokines in pregnancy/early abortion: Reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 2004; 134: 93–119
   PubMed Web of Science ®Google Scholar
• Beller F K. Low-dose endotoxin infusion: A new model?. Am J Obstet Gynecol 1995; 172: 1634–1635
   PubMed Web of Science ®Google Scholar
• Faas M M, Schuiling G A, Linton E A, Sargent I L, Redman C W. Activation of peripheral leukocytes in rat pregnancy and experimental preeclampsia. Am J Obstet Gynecol 2000; 182: 351–357
   PubMed Web of Science ®Google Scholar
• Faas M M, Broekema M, Moes H, van der S G, Heineman M J, de Vos P. Altered monocyte function in experimental preeclampsia in the rat. Am J Obstet Gynecol 2004; 191: 1192–1198
   PubMed Web of Science ®Google Scholar